← Eichor
Study identifier: NCT05189860 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The C-MIC-II Follow-Up Study

Condition: Systolic Left Ventricular Dysfunction  ·  Sponsor: Berlin Heals GmbH

PhaseNA
Planned participants31
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The C-MIC System is a medical device used to treat heart failure per the intended purpose which is to treat heart failure by applying an electrical micro-current to the heart. Target patients for this study are patients who have received the device in a prior study.

This description comes directly from the study's public registry record.

Talk to the study team

Peter Goettel, MD  ·  +49 30 88913640  ·  goettel@berlinheals.de

Kersten Brandes, MD  ·  +49 30 88913640  ·  brandes@berlinheals.de

Always discuss trial participation with your own doctor first.

Locations (6)

University Clinical Centre of Republic of SrpskaBanja Luka, Banja Luka, Bosnia and HerzegovinaNot Yet Recruiting
University Clinical Center of SarajevoSarajevo, Sarajevo, Bosnia and HerzegovinaNot Yet Recruiting
Clinical Hospital DubravaZagreb, City of Zagreb, CroatiaRecruiting
University Clinic Cardiac SurgerySkopje, North MacedoniaRecruiting
Clinical Center of SerbiaBelgrade, SerbiaRecruiting
Clinical Hospital Center Bezanijska KosaBelgrade, SerbiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05189860